Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Card Surg ; 29(4): 529-30, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24862431

RESUMO

Acute type A aortic dissection complicated by cardiac tamponade portends a lethal prognosis. We report the unusual case of an older female who unexpectedly survived for more than one year after presentation with acute dissection and tamponade. She was treated with a pericardial window and remains alive now four years after presentation.


Assuntos
Aneurisma Aórtico/complicações , Aneurisma Aórtico/cirurgia , Dissecção Aórtica/complicações , Dissecção Aórtica/cirurgia , Tamponamento Cardíaco/complicações , Técnicas de Janela Pericárdica , Sobrevida , Doença Aguda , Idoso de 80 Anos ou mais , Dissecção Aórtica/mortalidade , Aneurisma Aórtico/mortalidade , Tamponamento Cardíaco/mortalidade , Feminino , Humanos , Técnicas de Janela Pericárdica/mortalidade , Fatores de Tempo , Recusa do Paciente ao Tratamento
2.
J Cardiothorac Vasc Anesth ; 28(2): 274-9, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24231193

RESUMO

OBJECTIVE: In 2005, after the identification of cardiovascular safety concerns with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), the FDA issued a black box warning recommending against the use of NSAIDs following cardiac surgery. The goal of this study was to assess the postoperative safety of ketorolac, an intravenously administered NSAID, after cardiac surgery. DESIGN: Retrospective observational study. SETTING: Single center, regional hospital. PARTICIPANTS: A total of 1,309 cardiac surgical patients (78.1% coronary bypass, 28.0% valve) treated between 2006 and 2012. INTERVENTIONS: A total of 488 of these patients received ketorolac for postoperative analgesia within 72 hours of surgery. MEASUREMENT AND MAIN RESULTS: Ketorolac-treated patients were younger, had better preoperative renal function, and underwent less complex operations compared with non-ketorolac patients. Ketorolac was administered, on average, 8.7 hours after surgery (mean doses: 3.1). Postoperative outcomes for ketorolac-treated patients were similar to those expected using Society of Thoracic Surgery database risk-adjusted outcomes. In unadjusted analysis, patients who received ketorolac had similar or better postoperative outcomes compared with patients who did not receive ketorolac, including gastrointestinal bleeding (1.2% v 1.3%; p = 1.0), renal failure requiring dialysis (0.4% v 3.0%; p = 0.001), perioperative myocardial infarction (1.0% v 0.6%; p = 0.51), stroke or transient ischemic attack (1.0% v 1.7%; p = 0.47), and death (0.4% v 5.8%; p<0.0001). With adjustment in a multivariate model, treatment with ketorolac was not a predictor for adverse outcome in this cohort (odds ratio: 0.72; p = 0.23). CONCLUSIONS: Ketorolac appears to be well-tolerated for use when administered selectively after cardiac surgery. Although a black box warning exists, the data highlights the need for further research regarding its perioperative administration.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Procedimentos Cirúrgicos Cardíacos/métodos , Cetorolaco/efeitos adversos , Dor Pós-Operatória/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Anti-Inflamatórios não Esteroides/uso terapêutico , Procedimentos Cirúrgicos Cardíacos/mortalidade , Estudos de Coortes , Ponte de Artéria Coronária , Creatinina/sangue , Bases de Dados Factuais , Diálise , Feminino , Humanos , Cetorolaco/uso terapêutico , Testes de Função Renal , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Hemorragia Pós-Operatória/epidemiologia , Hemorragia Pós-Operatória/terapia , Reoperação , Estudos Retrospectivos , Medição de Risco , Resultado do Tratamento
3.
J Cardiothorac Surg ; 8: 172, 2013 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-23842141

RESUMO

BACKGROUND: Low levels of high-density lipoprotein (HDL) purportedly increase the risk after coronary bypass surgery. This may relate to the development of saphenous vein graft (SVG) disease early postoperatively, but this premise has never been evaluated in the context of a prospective trial. METHODS: The CASCADE Trial was a multi-center study of 113 patients evaluating the use of postoperative clopidogrel. Patients received standard lipid management after surgery (96% statins). At 12 months, angiography and intravascular ultrasound was performed to assess SVG occlusion and intimal hyperplasia, respectively. In this exploratory analysis, we evaluated the influence of HDL levels on the development of SVG disease at 12 months, using the established cut-off of <40 mg/dL suggesting increased risk. RESULTS: While HDL levels increased over the time-period of the trial (P < 0.0001), 51.1% of patients had HDL levels <40 mg/dL 12 months after surgery. Slightly more SVG occlusions occurred amongst patients with HDL levels <40 mg/dL (6.8%), compared to patients with HDL levels >40 mg/dL (4.0%, P = 0.5). With multivariate adjustment, HDL level <40 mg/dL was associated with a trend towards more SVG occlusions (odds ratio: 3.2; P = 0.12). Lower HDL level was also associated with more intimal hyperplasia on ultrasound at 12 months (P = 0.10). Patients who had HDL levels >60 mg/dL had the least amount of intimal hyperplasia, significantly less than the remainder of the cohort (P = 0.01). CONCLUSIONS: Within this population, lower HDL levels were associated with trends towards more graft occlusions and more vein intimal hyperplasia. Modulation of postoperative HDL levels may represent a valuable future strategy for the reduction of SVG disease.


Assuntos
Ponte de Artéria Coronária/efeitos adversos , Oclusão de Enxerto Vascular/etiologia , Lipoproteínas HDL/sangue , Inibidores da Agregação Plaquetária/uso terapêutico , Veia Safena/transplante , Ticlopidina/análogos & derivados , Idoso , Angiografia , Clopidogrel , Feminino , Seguimentos , Humanos , Hiperplasia , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório , Medição de Risco , Veia Safena/patologia , Ticlopidina/uso terapêutico , Túnica Íntima/patologia
4.
Gend Med ; 9(4): 219-31, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22819558

RESUMO

BACKGROUND: Aging kidneys exhibit slowly developing injury and women are usually protected compared with men, in association with maintained renal nitric oxide. OBJECTIVES: Our purpose was to test 2 hypotheses: (1) that aging intact Fischer-344 (F344) female rats exhibit less glomerular damage than similarly aged males, and (2) that loss of female ovarian hormones would lead to greater structural injury and dysregulation of the nitric oxide synthase (NOS) system in aging F344 rat kidneys. METHODS: We compared renal injury in F344 rats in intact, ovariectomized, and ovariectomized with estrogen replaced young (6 month) and old (24 month) female rats with young and old intact male rats and measured renal protein abundance of NOS isoforms and oxidative stress. RESULTS: There was no difference in age-dependent glomerular damage between young or old intact male and female F344 rats, and neither ovariectomy nor estrogen replacement affected renal injury; however, tubulointerstitial injury was greater in old males than in old females. These data suggest that ovarian hormones do not influence these aspects of kidney aging in F344 rats and that the greater tubulointerstitial injury is caused by male sex. Old males had greater kidney cortex NOS3 abundance than females, and NOS1 abundance (alpha and beta isoforms) was increased in old males compared with both young males and old females. NOS abundance was preserved with age in intact females, ovariectomy did not reduce NOS1 or NOS3 protein abundance, and estrogen replacement did not uniformly elevate NOS proteins, suggesting that estrogens are not primary regulators of renal NOS abundance in this strain. Nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production and nitrotyrosine immunoreactivity were increased in aging male rat kidneys compared with females, which could compromise renal nitric oxide production and/or bioavailability. CONCLUSIONS: The kidney damage expressed in aging F344 rats is fairly mild and is not related to loss of renal cortex NOS3 or NOS1 alpha.


Assuntos
Envelhecimento/metabolismo , Córtex Renal/metabolismo , Glomérulos Renais/metabolismo , Óxido Nítrico Sintase Tipo III/metabolismo , Óxido Nítrico Sintase Tipo I/metabolismo , Caracteres Sexuais , Fatores Etários , Animais , Modelos Animais de Doenças , Feminino , Masculino , Óxido Nítrico/metabolismo , Ratos , Ratos Endogâmicos F344
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...